ImmunoPrecise Antibodies Ltd. revenue breakdown overview

ImmunoPrecise Antibodies Ltd. revenue for the last year amounted to 17.80 M USD, the most of which — 16.47 M USD — came from its highest performing source at the moment, Antibody Production Project, the year earlier bringing 14.05 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ImmunoPrecise Antibodies Ltd. 9.30 M USD, and the year before that — 7.04 M USD.